The COVID-19 pandemic forced a mass experiment in telehealth that no evidence base, regulatory framework, or market incentive could have achieved otherwise. Within weeks of March 2020, CMS and private insurers suspended rules that had previously restricted telehealth to rural areas, required prior in-person relationships, and limited coverage to specific service codes. Utilization at peak pandemic reached levels 3,800% above pre-pandemic baselines. As restrictions eased and in-person care returned, utilization declined but stabilized at roughly 10× pre-pandemic levels — permanently embedding virtual care into the healthcare delivery landscape.
What Works Well Virtually
Five years of post-pandemic utilization data has produced reasonable consensus on telehealth's strongest use cases. Behavioral health leads: telepsychiatry and teletherapy show equivalent or superior outcomes to in-person care in most comparative studies, with dramatically improved access — particularly for rural, disabled, and working populations. Access to mental health services via telehealth increased 40% from 2019–2023, with telepsychiatry now delivering 60% of all outpatient mental health visits in some health systems. Chronic disease management — diabetes, hypertension, heart failure, COPD — with integrated remote monitoring devices (RPM) shows strong outcomes for reducing hospitalization rates and improving guideline adherence. Dermatology: store-and-forward teledermatology matches or exceeds in-person diagnosis accuracy for most common conditions (eczema, psoriasis, contact dermatitis) and dramatically reduces referral wait times. Urgent care for UTI, upper respiratory infection, and antibiotic prescribing for well-defined clinical presentations shows equivalent outcomes.
What Doesn't Work Well Virtually
Systematic reviews identify telehealth's limitations as clearly as its successes. Physical examination-dependent diagnoses (musculoskeletal injury, acute abdominal pain, new-onset cardiovascular symptoms) cannot be adequately assessed virtually, and telehealth providers ordering imaging for every uncertain patient encounter drives unnecessary healthcare utilization. Emergency triage via telemedicine has shown higher emergency department diversion rates — sending more patients to the ED — than in-person urgent care, negating potential access benefits. Mental health crisis management requires in-person safety assessment that video cannot replace. And the "digital divide" — 35 million Americans without broadband, disproportionately elderly, rural, and low-income — systematically excludes those with the highest healthcare need from telehealth benefits.
Remote Patient Monitoring: The High-Value Adjacent Technology
RPM — the integration of connected devices (blood pressure cuffs, pulse oximeters, weight scales, glucometers, CGMs) with clinical data platforms — has emerged as telehealth's highest-value application for chronic disease management. The CONNECT-HF trial demonstrated 15% reduction in 90-day rehospitalization for heart failure patients using structured RPM. Hypertension RPM programs consistently achieve significantly better blood pressure control than office-based care. CMS RPM billing codes (CPT 99453, 99454, 99457, 99458) have made RPM programs financially sustainable for primary care practices, with reimbursement averaging $110–180/patient/month for active monitoring. Facilities building RPM programs need reliable supplies of monitoring devices including FDA-cleared connected blood pressure monitors and pulse oximeters.
The Hybrid Care Model
The emerging clinical consensus is a hybrid care model: virtual visits for appropriate use cases, in-person care when physical examination adds diagnostic value, and RPM for ongoing chronic disease monitoring between episodic visits. Health systems including Kaiser Permanente, Geisinger, and Cleveland Clinic have formalized hybrid care pathways that triaged patients based on clinical need rather than availability — achieving primary care access improvements of 30–45% without proportional physician FTE increases. The regulatory landscape has mostly caught up: most pre-pandemic telehealth flexibilities have been made permanent or extended through 2025 reauthorizations, with audio-only telehealth access preserved for Medicare beneficiaries without reliable broadband.
